Jessica W Guite1,2,3,4, David D Sherry5,6, Esther W Jarvis5, Margaret O Lewen1,2,5, Sarosh Khan4, Francis Wickham Kraemer1,2. 1. Department of Anesthesiology & Critical Care Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. 2. Department of Anesthesiology & Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. 3. Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT 06032, USA. 4. Center for Behavioral Health, Connecticut Children's Medical Center, Hartford, CT 06106, USA. 5. Department of Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. 6. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract
AIM: To characterize medication use by adolescents with chronic musculoskeletal pain syndromes before an initial multidisciplinary clinic visit. PATIENTS & METHODS: A cross-sectional sample of 120 adolescents and parents reported on standardized assessment measures, with medication use data extracted from the medical chart and categorized. RESULTS: On average, 3.2 medications were reported; 70% used more than one pain-specific medication including opioids (17%), nonopioids (31%), psychotropics/neuropathics (45%) and other medications (13%). Adolescents with complex regional pain syndrome consistently reported greatest use of opioid, psychotropic/neuropathic and other pain medications. A regression model explained 17% of the variance in pain medication use. Nonpain medication use and disability contributed unique variance - pain duration and intensity did not. CONCLUSION: Greater attention to factors contributing to prescriptive practices, medication use and long-term outcomes is warranted.
AIM: To characterize medication use by adolescents with chronic musculoskeletal pain syndromes before an initial multidisciplinary clinic visit. PATIENTS & METHODS: A cross-sectional sample of 120 adolescents and parents reported on standardized assessment measures, with medication use data extracted from the medical chart and categorized. RESULTS: On average, 3.2 medications were reported; 70% used more than one pain-specific medication including opioids (17%), nonopioids (31%), psychotropics/neuropathics (45%) and other medications (13%). Adolescents with complex regional pain syndrome consistently reported greatest use of opioid, psychotropic/neuropathic and other pain medications. A regression model explained 17% of the variance in pain medication use. Nonpain medication use and disability contributed unique variance - pain duration and intensity did not. CONCLUSION: Greater attention to factors contributing to prescriptive practices, medication use and long-term outcomes is warranted.
Authors: Jessica W Guite; Sohee Kim; Chia-Pei Chen; Jennifer L Sherker; David D Sherry; John B Rose; Wei-Ting Hwang Journal: Clin J Pain Date: 2014-01 Impact factor: 3.442
Authors: Kathleen E Walsh; Kathleen M Mazor; Christopher J Stille; Irma Torres; Joann L Wagner; Juliet Moretti; Kevin Chysna; Christy D Stine; G Naheed Usmani; Jerry H Gurwitz Journal: Arch Dis Child Date: 2011-03-27 Impact factor: 3.791
Authors: Susmita Kashikar-Zuck; Stacy R Flowers; Robyn Lewis Claar; Jessica W Guite; Deirdre E Logan; Anne M Lynch-Jordan; Tonya M Palermo; Anna C Wilson Journal: Pain Date: 2011-03-31 Impact factor: 6.961
Authors: David D Sherry; Lori Brake; Jenna L Tress; Jennifer Sherker; Katherine Fash; Kelly Ferry; Pamela F Weiss Journal: J Pediatr Date: 2015-07-21 Impact factor: 4.406
Authors: Samina Ali; Katie Gourlay; Aran Yukseloglu; Rhonda J Rosychuk; Silvia Ortiz; Rick Watts; David W Johnson; Bruce Carleton; Sylvie Le May; Amy L Drendel Journal: BMJ Paediatr Open Date: 2022-05-24